Recently, Shanghai Medicilon Inc. (Medicilon) won the "Best Partner Award" from SicaGene. The strong support provided in collaboration projects has been recognized by client again. Medicilon and SicaGene: Go Deep Alone, Go Far Together The collaboration stems from a shared vision in the field of nucleic acid drugs. Antisense oligonucleotide drugs can break through the "undruggable targets" limitations of traditional small molecule drugs, but they also have extremely high technical barriers and development difficulties. As one of the first China innovative pharmaceutical companies to enter the ASO field, SicaGene has independently developed and constructed core technology platforms such as SicaScreenTM、SicaChemistryTM、SicaDeliveryTM , focusing on drug development in the fields of cardiovascular disease, viruses, and ophthalmology. SicaGene has also achieved efficient development of ASO drugs with high activity, low dosage, long administration cycle, g...
Integrated Drug Discovery Services- Chemistry, Biology & Preclinical Services